It is used in the treatment and prevention of vitamin B12 deficiency in patients with conditions such as: Addisonian (pernicious) anemia Malabsorption Atrophic gastritis Prolonged treatment with metformin Small bowel bacterial overgrowth (SIBO) Total or partial gastrectomy Infection with the fish parasite Diphyllobothrium latum Helicobacter pylori infection Pancreatic dysfunction Pancreatic or bowel malignancy Dietary deficiency (e.g
Yamamoto D, Ikeshita N, Daito R, Herningtyas EH, Toda K, Takahashi K, Iida K, Takahashi Y, Kaji H, Chihara K, Okimura Y
Clinical studies document specific benefits including retinal neuroprotection through neurotrophic factors, improved ocular blood flow enhancing nutrient delivery to photoreceptors, reduced inflammation in age-related macular degeneration, cellular repair accelerating recovery from retinal injury, and potential prevention of progressive vision loss in diabetic retinopathy
Description The present invention relates to new application forms of synthetic BPC (Body Protection Compound) peptides comprising 8 to 15 amino acid residues with a molecular weight of 900 to 1,600 daltons, which have organo-protective activity, to processes for their preparation and their use in diagnosis and therapy
Toxic Effects: Long-term use of glutathione supplements may lead to toxic effects on the nervous system, kidneys, and liver
